The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 06, 2024

Filed:

Aug. 24, 2023
Applicant:

Access Bio, Inc., Somerset, NJ (US);

Inventors:

Young Ho Choi, Belle Mead, NJ (US);

Jungho Back, Woodside, NY (US);

Hyoungsoo Kim, New Brunswick, NJ (US);

Hanmaru Chon, East Brunswick, NJ (US);

Myungkyu Jang, Daegu, KR;

Hyeon Suk Kim, Dayton, NJ (US);

Myoun Woo Kim, Somerset, NJ (US);

Hyewon Park, Somerset, NJ (US);

Suji Lee, Cherry Hill, NJ (US);

Olivia Haejeong Kim, Somerset, NJ (US);

Assignee:

Access Bio, Inc., Somerset, NJ (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/543 (2006.01); B01J 19/00 (2006.01); B01L 3/00 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
G01N 33/54391 (2021.08); B01J 19/0093 (2013.01); B01L 3/5029 (2013.01); B01L 3/56 (2013.01); G01N 33/54387 (2021.08); G01N 33/54389 (2021.08); G01N 33/56983 (2013.01); B01L 2200/0668 (2013.01); B01L 2300/0609 (2013.01); B01L 2300/0681 (2013.01); B01L 2300/069 (2013.01); B01L 2300/0809 (2013.01); B01L 2300/0825 (2013.01); G01N 2333/08 (2013.01); G01N 2333/165 (2013.01); G01N 2469/10 (2013.01);
Abstract

Diagnostic assay devices for detecting the presence of an analyte in a sample solution may comprise a microreactor configured to form a sample solution containing the analyte, flow the sample solution therethrough in a first direction to form an analyte-capture molecule complex, and transfer the sample solution to an absorbent strip pad configured to flow therethrough, in a second direction crossing the first direction, the sample solution including the analyte-capture molecule complex and indicate a presence of the analyte-capture molecule complex. The diagnostic devices may be used, for example, to identify the presence of SARS-Cov2, RSV, influenza A, influenza B or other pathogens in samples from patients.


Find Patent Forward Citations

Loading…